BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

373 related articles for article (PubMed ID: 33990576)

  • 1. Context-specific action of macrolide antibiotics on the eukaryotic ribosome.
    Svetlov MS; Koller TO; Meydan S; Shankar V; Klepacki D; Polacek N; Guydosh NR; Vázquez-Laslop N; Wilson DN; Mankin AS
    Nat Commun; 2021 May; 12(1):2803. PubMed ID: 33990576
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Interplay between the ribosomal tunnel, nascent chain, and macrolides influences drug inhibition.
    Starosta AL; Karpenko VV; Shishkina AV; Mikolajka A; Sumbatyan NV; Schluenzen F; Korshunova GA; Bogdanov AA; Wilson DN
    Chem Biol; 2010 May; 17(5):504-14. PubMed ID: 20534348
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Structural and mechanistic basis for translation inhibition by macrolide and ketolide antibiotics.
    Beckert B; Leroy EC; Sothiselvam S; Bock LV; Svetlov MS; Graf M; Arenz S; Abdelshahid M; Seip B; Grubmüller H; Mankin AS; Innis CA; Vázquez-Laslop N; Wilson DN
    Nat Commun; 2021 Jul; 12(1):4466. PubMed ID: 34294725
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Macrolide antibiotics allosterically predispose the ribosome for translation arrest.
    Sothiselvam S; Liu B; Han W; Ramu H; Klepacki D; Atkinson GC; Brauer A; Remm M; Tenson T; Schulten K; Vázquez-Laslop N; Mankin AS
    Proc Natl Acad Sci U S A; 2014 Jul; 111(27):9804-9. PubMed ID: 24961372
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Selective protein synthesis by ribosomes with a drug-obstructed exit tunnel.
    Kannan K; Vázquez-Laslop N; Mankin AS
    Cell; 2012 Oct; 151(3):508-20. PubMed ID: 23101624
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Macrolide antibiotics in the ribosome exit tunnel: species-specific binding and action.
    Kannan K; Mankin AS
    Ann N Y Acad Sci; 2011 Dec; 1241():33-47. PubMed ID: 22191525
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Kinetics of drug-ribosome interactions defines the cidality of macrolide antibiotics.
    Svetlov MS; Vázquez-Laslop N; Mankin AS
    Proc Natl Acad Sci U S A; 2017 Dec; 114(52):13673-13678. PubMed ID: 29229833
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Binding site of macrolide antibiotics on the ribosome: new resistance mutation identifies a specific interaction of ketolides with rRNA.
    Garza-Ramos G; Xiong L; Zhong P; Mankin A
    J Bacteriol; 2001 Dec; 183(23):6898-907. PubMed ID: 11698379
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The general mode of translation inhibition by macrolide antibiotics.
    Kannan K; Kanabar P; Schryer D; Florin T; Oh E; Bahroos N; Tenson T; Weissman JS; Mankin AS
    Proc Natl Acad Sci U S A; 2014 Nov; 111(45):15958-63. PubMed ID: 25349425
    [TBL] [Abstract][Full Text] [Related]  

  • 10. How Macrolide Antibiotics Work.
    Vázquez-Laslop N; Mankin AS
    Trends Biochem Sci; 2018 Sep; 43(9):668-684. PubMed ID: 30054232
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Binding of Macrolide Antibiotics Leads to Ribosomal Selection against Specific Substrates Based on Their Charge and Size.
    Sothiselvam S; Neuner S; Rigger L; Klepacki D; Micura R; Vázquez-Laslop N; Mankin AS
    Cell Rep; 2016 Aug; 16(7):1789-99. PubMed ID: 27498876
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Binding and action of CEM-101, a new fluoroketolide antibiotic that inhibits protein synthesis.
    Llano-Sotelo B; Dunkle J; Klepacki D; Zhang W; Fernandes P; Cate JH; Mankin AS
    Antimicrob Agents Chemother; 2010 Dec; 54(12):4961-70. PubMed ID: 20855725
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Insights into the improved macrolide inhibitory activity from the high-resolution cryo-EM structure of dirithromycin bound to the
    Pichkur EB; Paleskava A; Tereshchenkov AG; Kasatsky P; Komarova ES; Shiriaev DI; Bogdanov AA; Dontsova OA; Osterman IA; Sergiev PV; Polikanov YS; Myasnikov AG; Konevega AL
    RNA; 2020 Jun; 26(6):715-723. PubMed ID: 32144191
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A long-distance rRNA base pair impacts the ability of macrolide antibiotics to kill bacteria.
    Svetlov MS; Cohen S; Alsuhebany N; Vázquez-Laslop N; Mankin AS
    Proc Natl Acad Sci U S A; 2020 Jan; 117(4):1971-1975. PubMed ID: 31932436
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Two nucleotide substitutions in the A-site of yeast 18S rRNA affect translation and differentiate the interaction of ribosomes with aminoglycoside antibiotics.
    Tselika S; Konstantinidis TC; Synetos D
    Biochimie; 2008 Jun; 90(6):908-17. PubMed ID: 18331849
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Ribosomal tunnel and translation regulation.
    Bogdanov AA; Sumbatyan NV; Shishkina AV; Karpenko VV; Korshunova GA
    Biochemistry (Mosc); 2010 Dec; 75(13):1501-16. PubMed ID: 21417991
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Context-Specific Action of Ribosomal Antibiotics.
    Vázquez-Laslop N; Mankin AS
    Annu Rev Microbiol; 2018 Sep; 72():185-207. PubMed ID: 29906204
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Direct Measurements of Erythromycin's Effect on Protein Synthesis Kinetics in Living Bacterial Cells.
    Seefeldt AC; Aguirre Rivera J; Johansson M
    J Mol Biol; 2021 May; 433(10):166942. PubMed ID: 33744313
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Structural basis for the inhibition of the eukaryotic ribosome.
    Garreau de Loubresse N; Prokhorova I; Holtkamp W; Rodnina MV; Yusupova G; Yusupov M
    Nature; 2014 Sep; 513(7519):517-22. PubMed ID: 25209664
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Ribosomal antibiotics].
    Man'kin AS
    Mol Biol (Mosk); 2001; 35(4):597-609. PubMed ID: 11524946
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.